Literature DB >> 17096073

Model for end-stage liver disease (MELD) score and cost-effectiveness on living donor liver transplantation.

Takafumi Ichida, Yutaka Narita, Romi Murakami.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17096073     DOI： 10.1007/s00535-006-1959-y

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   6.772


× No keyword cloud information.
  13 in total

1.  Prediction of the prognosis in patients with acute-on-chronic hepatitis using the MELD scoring system.

Authors:  Jian-Wu Yu; Gui-Qiang Wang; Shu-Chen Li
Journal:  J Gastroenterol Hepatol       Date:  2006-10       Impact factor: 4.029

2.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

Review 3.  Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics.

Authors:  E Cholongitas; M Senzolo; D Patch; S Shaw; C Hui; A K Burroughs
Journal:  Aliment Pharmacol Ther       Date:  2006-08-01       Impact factor: 8.171

4.  Impact of dialysis and older age on survival after liver transplantation.

Authors:  E S Dellon; J A Galanko; R K Medapalli; M W Russo
Journal:  Am J Transplant       Date:  2006-07-06       Impact factor: 8.086

5.  Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective.

Authors:  F P Sarasin; P E Majno; J M Llovet; J Bruix; G Mentha; A Hadengue
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

Review 6.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

7.  Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B.

Authors:  Henry L-Y Chan; Angel M-L Chim; Joseph T-F Lau; Alex Y Hui; Vincent W-S Wong; Joseph J-Y Sung
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

8.  Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective.

Authors:  F P Sarasin; E Giostra; G Mentha; A Hadengue
Journal:  Hepatology       Date:  1998-08       Impact factor: 17.425

9.  Model for end-stage liver disease (MELD) and allocation of donor livers.

Authors:  Russell Wiesner; Erick Edwards; Richard Freeman; Ann Harper; Ray Kim; Patrick Kamath; Walter Kremers; John Lake; Todd Howard; Robert M Merion; Robert A Wolfe; Ruud Krom
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

10.  The model for end-stage liver disease score is useful for predicting economic outcomes in adult cases of living donor liver transplantation.

Authors:  Takayuki Kogure; Yoshiyuki Ueno; Naoki Kawagishi; Noriatsu Kanno; Yoko Yamagiwa; Koji Fukushima; Susumu Satomi; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2006-11-09       Impact factor: 6.772
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.